Kindred Biosciences Announces Second Quarter 2019 Financial Results and Unveils Positive Results from Pilot Efficacy Study of Parvovirus Monoclonal Antibody
Advertisement
- Mortality benefit seen in both prophylaxis and treatment of parvovirus infection